Acurx shareholders elect directors and ratify auditor at 2022 annual meeting

Acurx Pharmaceuticals, Inc.

Carl V. Sailer elected with 3,743,543 votes for, 289,750 withheld; broker non-votes 1,656,180.
Thomas Harrison elected with 3,741,578 votes for, 291,715 withheld; broker non-votes 1,656,180.
Ratification of CohnReznick LLP as auditor: 5,584,342 for, 98,801 against, 6,330 abstentions.

item 5.07

Acurx Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-068951

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.